Can Wegovy Cause an Irregular Period?

What the trial data actually recorded

The STEP 1 phase 3 trial (published in the New England Journal of Medicine and involving 1,961 adults without type 2 diabetes) was the foundational study for Wegovy's weight-management licence. Participants lost an average of around 15% of body weight over 68 weeks at the 2.4 mg maintenance dose. The trial was not designed to track menstrual outcomes as a primary endpoint, which is why you will not find a clean percentage labelled "irregular periods" in the headline results.

What the trial did confirm is substantial, rapid weight reduction. It is that weight loss, not solely the drug's pharmacology, that clinicians most often point to when patients raise cycle changes. Fat tissue produces oestrogen; losing it relatively quickly can shift the hormonal balance enough to alter cycle timing, flow or both. The NHS patient information for semaglutide does not list irregular periods among the common or very common side effects, but it does advise patients to report any unexpected changes to their prescriber.

Polycystic ovary syndrome (PCOS) adds another layer. PCOS is closely associated with excess weight, and many women starting Wegovy already have irregular cycles because of it. For some, improving insulin sensitivity and losing weight actually regularises their period over time; for others, the transition period brings disruption first. Keeping a simple note in your phone of cycle dates as you start treatment takes under a minute and gives your prescriber something concrete to work with.

Why weight loss and Wegovy are hard to separate as causes

When a patient reports a missed or erratic period after starting semaglutide, clinicians face a genuine attribution problem. The medicine reduces appetite, often sharply in the first weeks. Reduced calorie intake, even when deliberate and managed, can suppress the hypothalamic signals that regulate the menstrual cycle — an effect well documented in the general weight-loss literature and not unique to GLP-1 medicines.

There is also the matter of pace. Wegovy's dose escalation schedule is calibrated partly to manage tolerability, starting well below the therapeutic maintenance dose and stepping up over months. During that escalation phase, patients may experience their most pronounced gastrointestinal side effects alongside active, accelerating weight loss. This is precisely the window in which cycle changes are most commonly reported. Separating the drug's direct hormonal effect from the physiological consequence of losing weight quickly is, for most women, not practically possible without specialist testing.

The broader picture of how periods and Wegovy interact across the dose journey is worth reading if your pattern of changes has shifted at a particular dose stage.

Contraception, fertility and what to do if your period stops

A missed period while on Wegovy should prompt a pregnancy test first. Weight loss can actually restore ovulation in women who had irregular or absent cycles due to obesity or PCOS, which means fertility may return, sometimes before the woman realises it has. The NHS England guidance on weight-management injections specifically notes the importance of using reliable contraception throughout treatment and for a wash-out period before trying to conceive.

Women taking oral contraceptives should flag this to their prescriber. Vomiting or severe nausea in the early weeks of treatment can reduce absorption of the pill. For semaglutide, the evidence on pill absorption is less pronounced than for tirzepatide, but any consistent gastrointestinal disruption is worth discussing; a non-oral method may be a sensible addition during that period. You can read more about semaglutide's effects on menstruation in the dedicated page covering this topic.

If your period stops entirely for more than two consecutive cycles, or if changes are accompanied by other symptoms (pelvic pain, significant bloating, unusual discharge), those warrant a conversation with your GP rather than a wait-and-see approach. The absence of periods on Wegovy is explored in more detail separately, including the specific circumstances that need prompt review.

When to raise it with your prescriber

Irregular periods during the first few months of Wegovy treatment are not automatically a sign that something has gone wrong. Many women find their cycle settles once their weight stabilises and their body adjusts to the new hormonal environment. That said, there are situations where a prompt clinical conversation is the right call: periods that stop for more than two months without a clear explanation, very heavy or prolonged bleeding that is new for you, or a cycle pattern that is becoming more chaotic rather than settling as treatment continues.

At nume, every patient's treatment is reviewed by a GPhC-registered prescriber before each repeat, giving you a structured opportunity to raise exactly this kind of concern. If you are wondering about something between orders, our team is available seven days a week. The question of whether Wegovy directly causes irregular periods is answered with more clinical granularity on a dedicated page, and the general FAQs cover a wide range of treatment questions. If cost is a factor in your decision to start or continue treatment, the Wegovy cost page sets out what is included in private treatment. When you are ready, speaking to our prescribers is the practical next step.